Human Flt3 is expressed at the hematopoietic stem cell and the granulocyte/macrophage progenitor stages to maintain cell survival

Journal of Immunology

Volumn 180, Issue 11, 2008, Pages 7358-7367

  Kikushige, Yoshikane ^a   Yoshimoto, Goichi ^a   Miyamoto, Toshihiro ^a   Iino, Tadafumi ^a,c   Mori, Yasuo ^a   Iwasaki, Hiromi ^b   Niiro, Hiroaki ^a   Takenaka, Katsuto ^a   Nagafuji, Koji ^a   Harada, Mine ^a   Ishikawa, Fumihiko ^b   Akashi, Koichi ^a,c  

^a KYUSHU UNIVERSITY   (Japan)

^b RIKEN Center for Integrative Medical Sciences   (Japan)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD135 ANTIGEN; PROTEIN MCL 1; FLT3 PROTEIN, HUMAN; MYELOID CELL LEUKEMIA SEQUENCE 1 PROTEIN; PROTEIN BCL 2;

APOPTOSIS; ARTICLE; CELL DEATH; CELL SURVIVAL; CONTROLLED STUDY; GRANULOCYTE PRECURSOR; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; MACROPHAGE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; UMBILICAL CORD BLOOD; UPREGULATION; ANIMAL; BONE MARROW CELL; CYTOLOGY; ENZYMOLOGY; FETUS BLOOD; LYMPHOID PROGENITOR CELL; METABOLISM; MOUSE; MYELOID PROGENITOR CELL;

ANIMALS; APOPTOSIS; BONE MARROW CELLS; CELL SURVIVAL; FETAL BLOOD; FMS-LIKE TYROSINE KINASE 3; GRANULOCYTE PRECURSOR CELLS; HEMATOPOIESIS; HEMATOPOIETIC STEM CELLS; HUMANS; LYMPHOID PROGENITOR CELLS; MACROPHAGES; MICE; MYELOID PROGENITOR CELLS; PROTO-ONCOGENE PROTEINS C-BCL-2; UP-REGULATION;

EID: 47249144115     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.180.11.7358     Document Type: Article

References (57)

1. Ikuta, K., and I. L. Weissman. 1992. Evidence that hematopoietic stem cells express mouse c-kit but do not depend on steel factor for their generation. Proc. Natl. Acad. Sci. USA 89: 1502-1506.
2. Spangrude, G. J., S. Heimfeld, and I. L. Weissman. 1988. Purification and characterization of mouse hematopoietic stem cells. Science 241: 58-62.
3. Morrison, S. J., and I. L. Weissman. 1994. The long-term repopulating subset of hematopoietic stem cells is deterministic and isolatable by phenotype. Immunity 1: 661-673.
4. Osawa, M., K. Hanada, H. Hamada, and H. Nakauchi. 1996. Long-term lympho-hematopoietic reconstitution by a single CD34-low/negative hematopoietic stem cell. Science 273: 242-245.
5. Randall, T. D., F. E. Lund, M. C. Howard, and I. L. Weissman. 1996. Expression of murine CD38 defines a population of long-term reconstituting hematopoietic stem cells. Blood 87: 4057-4067.
6. Kondo, M., I. L. Weissman, and K. Akashi. 1997. Identification of clonogenic common lymphoid progenitors in mouse bone marrow. Cell 91: 661-672.
7. Akashi, K., D. Traver, T. Miyamoto, and I. L. Weissman. 2000. A clonogenic common myeloid progenitor that gives rise to all myeloid lineages. Nature 404: 193-197.
8. Okuno, Y., H. Iwasaki, C. S. Huettner, H. S. Radomska, D. A. Gonzalez, D. G. Tenen, and K. Akashi. 2002. Differential regulation of the human and murine CD34 genes in hematopoietic stem cells. Proc. Natl. Acad. Sci. USA 99: 6246-6251.
9. - progenitor cells. Blood 77: 1218-1227.
10. + CD38. Lcukemia 17: 960-964.
11. Craig, W., R. Kay, R. L. Cutler, and P. M. Lansdorp. 1993. Expression of Thy-1 on human hematopoietic progenitor cells. J. Exp. Med. 177: 1331-1342.
12. - subpopulation from mobilized peripheral blood. Blood 85: 368-378.
13. Baum, C. M., I. L. Weissman, A. S. Tsukamoto, A. M. Buckle, and B. Peault. 1992. Isolation of a candidate human hematopoietic stem-cell population. Proc. Natl. Acad. Sci. USA 89: 2804-2808.
14. Manz, M. G., T. Miyamoto, K. Akashi, and I. L. Weissman. 2002. Prospective isolation of human clonogenic common myeloid progenitors. Proc. Natl. Acad. Sci. USA 99: 11872-11877.
15. Galy, A., M. Travis, D. Cen, and B. Chen. 1995. Human T, B, natural killer, and dendritic cells arise from a common bone marrow progenitor cell subset. Immunity 3: 459-473.
16. +) stem cell compartment is accompanied by loss of self-renewal capacity. Immunity 15: 659-669.
17. Christensen, J. L., and I. L. Weissman. 2001. Flk-2 is a marker in hematopoietic stem cell differentiation: a simple method to isolate long-term stem cells. Proc. Natl. Acad. Sci. USA 98: 14541-14546.
18. + lympho-myeloid stem cells lacking erythro-megakaryocytic potential a revised road map for adult blood lineage commitment. Cell 121: 295-306.
19. + mulltipotent hematopoietic progenitors. Cell 126: 415-426.
20. D'Amico, A., and L. Wu. 2003. The early progenitors of mouse dendritic cells and plasmacytoid predendritic cells are within the bone marrow hemopoietic precursors expressing Flt3. J. Exp. Med. 198: 293-303.
21. + dendritic cells in vivo. J. Exp. Med. 198: 305-313.
22. Sitnicka, E., D. Bryder, K. Theilgaard-Monch, N. Buza-Vidas, J. Adolfsson, and S. E. Jacobsen. 2002. Key role of flt3 ligand in regulation of the common lymphoid progenitor but not in maintenance of the hematopoietic stem cell pool. Immunity 17: 463-472.
23. Rappold, I, B. L. Ziegler, I. Kohler, S. Marchetto, O. Rosnet, D. Birnbaum, P. J. Simmons, A. C. Zannettino, B. Hill, S. Neu, et al. 1997. Functional and phenotypic characterization of cord blood and bone marrow subsets expressing FLT3 (CDI35) receptor tyrosine kinase. Blood 90: 111-125.
24. + hematopoietic stem cells capable of multilineage engrafting NOD/SCID mice express flt3: distinct flt3 and c-kit expression and response patterns on mouse and candidate human hematopoietic stem cells. Blood 102: 881-886.
25. + progenitor cells isolated from human bone marrow are functionally distinct. Blood 91: 1947-1958.
26. Carow, C. E., M. Levenstein, S. H. Kaufmann, J. Chen, S. Amin, P. Rockwell, L. Witte, M. J. Borowitz, C. I. Civin, and D. Small. 1996. Expression of the hematopoietic growth factor receptor FLT3 (STK-1/Flk2) in human leukemias. Blood 87: 1089-1096.
27. Rosnet, O., H. J. Buhring, S. Marchetto, I. Rappold, C. Lavagna, D. Sainty, C. Amoulet, C. Chabannon, L. Kanz, C. Hannum, and D. Birnbaum. 1996. Human FLT3/FLK2 receptor tyrosine kinase is expressed at the surface of normal and malignant hematopoietic cells. Leukemia 10: 238-248.
28. Stirewalt, D. L., and J. P. Radich. 2003. The role of FLT3 in haematopoietic malignancies. Nat. Rev. Cancer 3: 650-665.
29. Gilliland, D. G., and J. D. Griffin. 2002. The roles of FLT3 in hematopoiesis and leukemia. Blood 100: 1532-1542.
30. Kiyoi, H., T. Naoe, Y. Nakano, S. Yokota, S. Minami, S. Miyawaki, N. Asou, K. Kuriyama, I. Jinnai, C. Shimazaki, et al. 1999. Prognostic implication of FLT3 and N-RAS gene mutations in acute myeloid leukemia. Blood 93: 3074-3080.
31. Schniltger, S., C. Schoch, M. Dugas, W. Kern, P. Staib, C. Wuchter, H. Loffler, C. M. Sauerland, H. Serve, T. Buchner, et al. 2002. Analysis of FLT3 length mutations in 1003 patients with acute myeloid leukemia: correlation to cytogenetics, FAB subtype, and prognosis in the AMLCG study and usefulness as a marker for the detection of minimal residual disease. Blood 100: 59-66.
32. Thiede, C, C. Steudel, B. Mohr, M. Schaich, U. Schakel, U. Platzbecker, M. Wermke, M. Bornhauser, M. Ritter, A. Neubauer, et al. 2002. Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: association with FAB subtypes and identification of subgroups with poor prognosis. Blood 99: 4326-4335.
33. Ishikawa, F., M. Yasukawa, B. Lyons, S. Yoshida, T. Miyamoto, G. Yoshimoto, T. Watanabe, K. Akashi, L. D. Shultz, and M. Harada. 2005. Development of functional human blood and immune systems in NOD/SCID/IL2 receptor γ chain(null) mice. Blood 106: 1565-1573.
34. Kozopas, K. M., T. Yang, H. L. Buchan, P. Zhou, and R. W. Craig. 1993. MCL1, a gene expressed in programmed myeloid cell differentiation, has sequence similarity to BCL2. Proc. Natl. Acad. Sci. USA 90: 3516-3520.
35. Miyamoto, T., I. L. Weissman, and K. Akashi. 2000. AML1/ETO-expressing nonleukemic stem cells in acute myelogenous leukemia with 8;21 chromosomal translocation. Proc. Natl. Acad. Sci. USA 97: 7521-7526.
36. Cao, X., E. W. Shores, J. Hu-Li, M. R. Anver, B. L. Kelsall, S. M. Russell, J. Drago, M. Noguchi, A. Grinberg, E. T. Bloom, et al. 1995. Defective lymphoid development in mice lacking expression of the common cytokine receptor γ chain. Immunity 2: 223-238.
37. Shultz, L. D., B. L. Lyons, L. M. Burzenski, B. Gott, X. Chen, S. Chaleff, M. Kotb, S. D. Gillies, M. King, J. Mangada, D. L. Greiner, and R. Handgretinger. 2005. Human lymphoid and myeloid cell development in NOD/LtSz-scid IL2R γ null mice engrafted with mobilized human hemopoietic stem cells. J. Immunol. 174: 6477-6489.
38. - cells expressing FIk2/Flt3. Br. J. Haematol. 119: 525-534.
39. Ryan, D. H., B. L. Nuccie, I. Ritterman, J. L. Liesveld, C. N. Abboud, and R. A. Insel. 1997. Expression of interleukin-7 receptor by lineage-negative human bone marrow progenitors with enhanced lymphoid proliferative potential and B-lineage differentiation capacity. Blood 89: 929-940.
40. LeBien, T. W. 2000. Fates of human B-cell precursors. Blood 96: 9-23.
41. Chicha, L., D. Jarrossay, and M. G. Manz. 2004. Clonal type I interferon-producing and dendritic cell precursors are contained in both human lymphoid and myeloid progenitor populations. J. Exp. Med. 200: 1519-1524.
42. Majeti, R., C. Y. Park, and I. L. Weissman. 2007. Identification of a hierarchy of multipotent hematopoietic progenitors in human cord blood. Cell Stem Cell. 1: 635-645.
43. van Engeland, M., L. J. Nieland, F. C. Ramaekers, B. Schutte, and C. P. Reutelingsperger. 1998. Annexin V-affinity assay: a review on an apoptosis detection system based on phosphatidylserine exposure. Cytometry 31: 1-9.
44. Gilliland, D. G., and J. D. Griffin. 2002. Role of FLT3 in leukemia. Curr. Opin. Hematol. 9: 274-281.
45. Opferman, J. T., H. Iwasaki, C. C. Ong, H. Sub, S. Mizuno, K. Akashi, and S. J. Korsmeyer. 2005. Obligate role of anti-apoptotic MCL-1 in the survival of hematopoietic stem cells. Science 307: 1101-1104.
46. -cells and maintains progenitor cells in vitro. Blood 87: 3563-3570.
47. Gabbianelli, M., E. Pelosi, E. Montesoro, M. Valtieri, L. Luchetti, P. Samoggia, L. Vitelli, T. Barberi, U. Testa, S. Lyman, et al. 1995. Multi-level effects of flt3 ligand on human hematopoiesis: expansion of putative stem cells and proliferation of granulomonocytic progenitors/monocytic precursors. Blood 86: 1661-1670.
48. Witte, O. N. 1990. Steel locus defines new multipotent growth factor. Cell 63: 5-6.
49. Nakayama, K., K. Nakayama, I. Negishi, K. Kuida, H. Sawa, and D. Y. Loh. 1994. Targeted disruption of Bcl-2 α βin mice: occurrence of gray hair, polycystic kidney disease, and lymphocytopenia. Proc. Natl. Acad. Sci. USA 91: 3700-3704.
50. Akashi, K., M. Kondo, U. von Freeden-Jeffry, R. Murray, and I. L. Weissman. 1997. Bcl-2 rescues T lymphopoiesis in interleukin-7 receptor-deficient mice. Cell 89: 1033-1041.
51. Opferman, J. T., A. Letai, C. Beard, M. D. Sorcinelli, C. C. Ong, and S. J. Korsmeyer. 2003. Development and maintenance of B and T lymphocytes requires antiapoptotic MCL-1. Nature 426: 671-676.
52. Kelly, L. M., Q. Liu, J. L. Kutok, I. R. Williams, C. L. Boulton, and D. G. Gilliland. 2002. FLT3 internal tandem duplication mutations associated with human acute myeloid leukemias induce myeloproliferative disease in a marine bone marrow transplant model. Blood 99: 310-318.
53. Traver, D., K. Akashi, I. L. Weissman, and E. Lagasse. 1998. Mice defective in two apoptosis pathways in the myeloid lineage develop acute myeloblastic leukemia. Immunity 9: 47-57.
54. Jaiswal, S., D. Traver, T. Miyamoto, K. Akashi, E. Lagasse, and I. L. Weissman. 2003. Expression of BCR/ABL and BCL-2 in myeloid progenitors leads to myeloid leukemias. Proc. Natl. Acad. Sci. USA 100: 10002-10007.
55. Jamieson, C. H., L. E. Allies, S. J. Dylla, M. Muijtjens, C. Jones, J. L. Zehnder, J. Gotlib, K. Li, M. G. Manz, A. Keating, et al. 2004. Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML. N. Engl. J. Med. 351:657-667.
56. Cozzio, A., E. Passegue, P. M. Ayton, H. Karsunky, M. L. Cleary, and I. L. Weissman. 2003. Similar MLL-associated leukemias arising from self-renewing stem cells and short-lived myeloid progenitors. Genes Dev. 17: 3029-3035.
57. Huntly, B. J., H. Shigematsu, K. Deguchi, B. H. Lee, S. Mizuno, N. Duclos, R. Rowan, S. Amaral, D. Curley, I. R. Williams, et al. 2004. MOZ-TIF2, but not BCR-ABL, confers properties of leukemic stem cells to committed murine hematopoietic progenitors. Cancer Cell. 6: 587-596.